Patients with certain medical conditions, including MEN2, medullary thyroid carcinoma, or pregnancy, may not be eligible
Patients who typically drink very little or who run chronically low urine volumes may also need to be especially attentive when starting a GLP1 therapy
Furthermore, the guidelines advise medical professionals to think about postponing surgeries if the patient reports significant gastrointestinal symptoms on the day of the procedure, such as pronounced nausea, vomiting, abdominal discomfort, or bloating
Throughout this process, it is crucial to avoid unapproved compounded products or research chemicals. The FDA has warned about dosing errors and adverse events from compounded semaglutide and other non-approved GLP-1 formulations sold online
For symptoms that feel medically urgent, seek emergency care immediately and do not wait for a telehealth response